Cue Biopharma, Inc.
CUE
Revenue
2.66M
▲941.00k▲54.80%
3 Months ChangeAssets
42.33M
▼-11.62M▼-21.54%
3 Months ChangeLiabilities
20.71M
▼-3.21M▼-13.41%
3 Months ChangeFree Cash Flow
-9.84M
▲994.00k▲9.18%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-08
Form 8-K
ID: 0000950170-24-113520
2024-10-04
Form 8-K
ID: 0000950170-24-112887
2024-09-27
Form 8-K
ID: 0001193125-24-227977
2024-09-03
Form 8-K
ID: 0000950170-24-102851
2024-08-16
Form 8-K
ID: 0000950170-24-098032
2024-08-14
Form 10-Q
ID: 0000950170-24-096967
2024-07-25
Form 8-K
ID: 0000950170-24-086476
2024-06-07
Form 8-K
ID: 0000950170-24-070566
2024-05-09
Form 8-K
ID: 0000950170-24-056848
2024-05-09
Form 10-Q
ID: 0000950170-24-056838